Integra Lifesciences Holdings (IART) FCF Margin Growth (3y) (2012 - 2026)
Integra Lifesciences Holdings (IART) FCF Margin Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | 884.00 |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | 534.00 |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | -310.00 |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 919.00 |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | 3,472.00 |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | -97.00 |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 413.00 |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -63.00 |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 60.00 |
| 10 | Integra Lifesciences Holdings | 1.30 Bn | 1.02 Bn | 219.74 Mn | -83.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -83.00 |
| Mar 31, 2026 | -456.00 |
| Dec 31, 2025 | -1,905.00 |
| Sep 30, 2025 | -895.00 |
| Jun 30, 2025 | -1,705.00 |
| Mar 31, 2025 | -1,980.00 |
| Dec 31, 2024 | -554.00 |
| Sep 30, 2024 | -2,139.00 |
| Jun 30, 2024 | -1,915.00 |
| Mar 31, 2024 | -1,725.00 |
| Dec 31, 2023 | -987.00 |
| Sep 30, 2023 | -1,341.00 |
| Jun 30, 2023 | -667.00 |
| Mar 31, 2023 | 206.00 |
| Dec 31, 2022 | 85.00 |
| Sep 30, 2022 | 200.00 |
| Jun 30, 2022 | 630.00 |
| Mar 31, 2022 | 557.00 |
| Dec 31, 2021 | 588.00 |
| Sep 30, 2021 | 241.00 |